Surface plasmon resonance (SPR) has long been the gold standard for characterising molecular interactions in drug discovery, but throughput limitations have historically constrained its use in early-stage screening campaigns where large numbers of compounds or biologics candidates require rapid triage. The Carterra Vega changes that equation.
This webinar introduces the Vega – Carterra’s newest SPR platform engineered with a 48-channel array format, with two ligands per channel, that enables kinetic and affinity data to be collected across an entire compound library in a single multiplexed run. Current SPR platforms are limited to a maximum of eight channels. Building on Carterra’s legacy of array-based SPR innovation, the Vega substantially increases the throughput of high-quality binding data that can be generated relative to conventional sequential SPR methods.
By enabling simultaneous kinetic and affinity characterisation across 48 channels in a single run, the Vega offers a practical solution to one of the more persistent bottlenecks in early-stage drug discovery — generating high-quality binding data at the pace that contemporary screening workflows demand.
You will learn:
- The Carterra Vega Platform – How 48-channel array-based SPR enables simultaneous label-free binding characterisation, and how the analysis software supports efficient data processing and decision-making across large data sets.
- Small Molecule Screening – how parallel SPR addresses throughput limitations in fragment-based and lead compound screening, delivering kinetic and affinity data at a scale not previously achievable with label-free methods.
- Large Molecule Characterisation – how the Vega supports simultaneous antibody kinetics, affinity measurement, and epitope binning across large candidate panels without compromising data quality or sample consumption.
Register and watch the webinar now!
Supported by
